(Alliance News) - Ulisse Biomed Spa announced Friday that it has signed a two-year worldwide distribution agreement for products in the HPV Selfy range with ELITechGroup Spa, an integrated in vitro diagnostics company that serves hospitals and diagnostic laboratories in more than 100 countries through a direct sales organization and through third-party distribution partners.

The products covered by the agreement are two Human Papillomavirus detection and genotyping tests from Selfy's HPV range based on Sagitta's proprietary patented technology.

The agreement provides for the promotion and marketing of the products on an exclusive basis to customers using platforms made by ELITech and non-exclusive to customers using open platforms.

In addition, the company explains in a note, the agreement "will allow Ulisse Biomed to expand its commercial reach and supply the products to a wider range of customers and will provide those customers with access to extensive support and service."

Ulisse Biomed on Friday closed 2.0 percent in the red at EUR1.06 per share.

By Chiara Bruschi, Alliance News reporter

Comments and questions to redazione@alliancenews.com

Copyright 2023 Alliance News IS Italian Service Ltd. All rights reserved.